Related Experiment Video
Updated: Aug 8, 2026

05:14
Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
Published on: September 16, 2025
The effect of phenylephrine and cyclopentolate on objective wavefront measurements
Mirko R Jankov1, Hans Peter Iseli, Michael Bueeler
1Milos Clinic Eye Hospital, Belgrade, Serbia and Montenegro. visioncare@mac.com
Summary
Phenylephrine causes myopic shift and accommodation, while cyclopentolate provides a stable, model-like refraction. Fogging accommodation targets is recommended for accurate wavefront measurements.
Area of Science:
- Ophthalmology
- Optometry
- Vision Science
Background:
- Accurate refractive error assessment is crucial for visual function.
- Wavefront aberrometry provides detailed information about optical aberrations.
- Understanding the impact of cycloplegic agents on wavefront measurements is essential.
Purpose of the Study:
- To evaluate the effects of phenylephrine and cyclopentolate on wavefront refraction.
- To analyze the influence of these agents on fourth-order spherical aberration (C12).
- To determine optimal conditions for wavefront measurement.
Main Methods:
- A cohort study of 151 eyes using wavefront aberrometry (ALLEGRO WAVE).
- Objective refraction measured after phenylephrine (accommodated) and cyclopentolate (non-accommodated).
- Wavefront aberrations analyzed using Zernike expansion; objective wavefront sphere calculated.
Main Results:
- Phenylephrine induced a significant myopic shift (-0.66 D) due to accommodation.
- Cyclopentolate resulted in refraction close to a model eye (-0.08 D difference).
- Fourth-order spherical aberration (C12) sign changed significantly between phenylephrine and cyclopentolate at 7.0 mm pupil size.
Conclusions:
- Accommodation target fogging is recommended for reliable wavefront measurements.
- Weaker cycloplegics like tropicamide may offer a balance between relaxation and natural aberration values.
- These findings aid in standardizing wavefront analysis for clinical applications.